Drug maker Hospira Inc. (NYSE:HSP) objects to its drugs being used in recent controversial Ohio execution. Hospira, Inc. (NYSE:HSP) stock opened at $43.90 in last session, and closed at $42.27, while the day range of Hospira, Inc. (NYSE:HSP) stock is $41.86 – $43.90. The stock showed a positive weekly performance of -4.17%.
Generex Biotechnology Corporation (OTCMKTS:GNBT) is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Generex Biotechnology Corporation (OTCMKTS:GNBT) stock opened at $0.03 in last session, and closed at $0.0350 by gaining 0.00%. The 52 week range of $0.02 – $0.06. Company’s market capitalization is $9.48M.
The Canadian drug maker Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) will report Q4 earnings Feb. 27. Analysts polled by Thomson Reuters see profit jumping 69% to $2.06 a share. Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) stock decreased -1.18% and finished the last session at $146.26. The EPS of the stock remained -3.26. Company’s market capitalization is $48.80B.
Delcath Systems, Inc.(NASDAQ:DCTH) holds great hopes for its product the Delath Chemosaturatoin System as the drug is known to offer regional chemotherapy, through the process of isolation of circulatory system of the organs. It is believed that once the system is isolated, it allows the delivery of doses of these chemotherapeutic agents to the liver directly. It also involves the isolation of the circulatory system of the organ under consideration. Delcath Systems, Inc. (NASDAQ:DCTH) stock opened the session at $0.32, and closed the session at $0.305. The 52 week range of the Delcath Systems, Inc. (NASDAQ:DCTH) stock remained $0.22 – $2.19 and the day range was $0.31 – $0.32.